Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert


Search Title by author or title

Zero-phaco approach with the LENSAR femtosecond laser system

Poster Details

First Author: G. Auffarth GERMANY

Co Author(s):    B. Giers   T. Tandogan   R. Khoramnia              

Abstract Details


To evaluate Femtosecond-Laser assissted cataract surgery using the LENSAR Laser in conjunction with an aspiration-only special handpiece for lens removal.


International Vision Correction Research Center and the David J Apple International Laboratory for Ocular Pathology, Dept. of Ophthalmology, University of Heidelberg


The LENSAR Femtosecond cataract laser system (LENSAR, LLC) is a combination of a Femtosecond laser with a Scheimpflug-based diagnostic system. The anterior segment is analysed with a rotating Scheimpflug camera creating images that give information about corneal curvature and lens morphology including density of the cataract. Using the cubic-type pre-fragmentation mode of the LENSAR laser, cataractous lenses were treated and the contents of the lens were removed with a special irrigation-only handpiece (ZeroPhaco, Bausch + Lomb).


In contrast to bimanual I/A or monomanual I/A handpieces, this special handpiece for Femtosecond laser-assisted cataract surgery has a similar configuration as a normal phaco-handpiece, but is not using ultrasound. With the LENSAR we could perform zero-phaco, aspiration-only surgery in cataract densities of up to +3, which could be easily identified with the LENSAR imaging system.


The poster displays results and video-footage of lens-removal with an aspiration-only handpiece based on previous evaluation with the LENSAR Scheimpflug imaging system.

Financial Disclosure:

One or more of the authors receives consulting fees, retainer, or contract payments from a competing company, One or more of the authors travel has been funded, fully or partially, by a competing company, One or more of the authors research is funded, fully or partially, by a competing company, One or more of the authors receives nonNONEmonetary benefits from a competing company.

Back to Poster listing